GOAB

This brand name is authorized in Nigeria.

Active ingredients

The drug GOAB contains one active pharmaceutical ingredient (API):

1	Solifenacin UNII KKA5DLD701 - SOLIFENACIN SUCCINATE
	Solifenacin is a competitive, specific cholinergic-receptor antagonist. In vitro and in vivo pharmacological studies indicate that solifenacin is a competitive inhibitor of the muscarinic M3 subtype receptor.
	Read more about Solifenacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100712	Tablet	Goab 10 Tablets TAB 10 mg 3 x 10's (in blisters)	Film coated tablet. White to off white color, round, biconvex tablets debossed “V”on one side and “19”	31/01/2024
A4-100727	Tablet	GOAB 5 Tablets TAB 5 mg 3 x 10's (in blisters)	Film-coated tablet. White to off-white color, round, biconvex tablets debossed "V" on one side and "18"	31/01/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G04BD08	Solifenacin	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BD Urinary antispasmodics
Discover more medicines within G04BD08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100712, A4-100727